Illustration: Sarah Grillo/Axios

Now that the initial shock has worn off from today's Korean news, here's a brief survey of the reasons for skepticism and optimism about peace and denuclearization.

Why it matters: Today is only the beginning of a lengthy process, and we've been burned by early optimism in the past.

Skepticism:

  • "North and South Korean leaders have signed grand peace documents before, in 2000 and 2007, and neither lasted. In 2012, North Korea agreed not to test missiles and then weeks later fired one off but called it a 'satellite' launch." [NYT's Nicholas Kristof]
  • Kim Jong-un "may also be exhibiting a degree of confidence and security because of his nuclear weapons and ballistic missiles, which suggests he is unlikely to give them up." [Richard Haass]
  • The language released today "hews to a phrase preferred by Pyongyang that critics of the rapprochement say conditions any North Korean actions on the withdrawal of the U.S. military from South Korea." [WSJ]
  • China could demand U.S. troops leave South Korea in exchange for a permanent peace treaty. [NYT's Choe Sang-Hun]
  • "We put [the odds of denuclearizing during Trump's first term] at 5 percent." [Eurasia Group's Meredith Sumpter]

Optimism:

  • "[T]he new actors (Kim, Moon and Trump) and new setting (a de facto nuclear North Korea under different leadership) might lead to a different ending this time." [Gi-Wook Shin]
  • "New U.S. Secretary of State Mike Pompeo said he believed Mr. Kim was serious about reaching a deal." [WSJ]
  • "It’s hard to see the U.S. credibly threatening military pre-emption when peace is breaking out across the peninsula — which is precisely the point." [Ian Bremmer]
  • "South Korean officials do not believe that Mr. Kim will swiftly relinquish his nuclear weapons. But there is a growing belief in Seoul that he might ultimately bargain them away, if it helps him rebuild the economy." [NYT]

Go deeper

Updated 1 min ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 9:30 p.m. ET: 31,467,508 — Total deaths: 967,881— Total recoveries: 21,583,915Map.
  2. U.S.: Total confirmed cases as of 9:30 p.m. ET: 6,890,662 — Total deaths: 200,710 — Total recoveries: 2,646,959 — Total tests: 96,612,436Map.
  3. Health: The U.S. reaches 200,000 coronavirus deaths — The CDC's crumbling reputation — America turns against coronavirus vaccine.
  4. Politics: Elected officials are failing us on much-needed stimulus.
  5. Business: Two-thirds of business leaders think pandemic will lead to permanent changes — Fed chair warns economy will feel the weight of expired stimulus.
  6. Sports: NFL fines maskless coaches.
Dan Primack, author of Pro Rata
1 hour ago - Economy & Business

GoodRx prices IPO at $33 per share, valued at $12.7 billion

Illustration: Sarah Grillo/Axios

GoodRx, a price comparison app for prescription drugs at local pharmacies, on Tuesday night raised $1.14 billion in its IPO, Axios has learned.

By the numbers: GoodRx priced its shares at $33 a piece, above its $24-$28 per share offering range, which will give it an initial market cap of around $12.7 billion.

Updated 1 hour ago - Politics & Policy

House Democrats and Trump admin strike deal to avert government shutdown

House Speaker Nancy Pelosi on Capitol Hill. Photo: Tom Williams/CQ-Roll Call via Getty Images

The House on Tuesday passed legislation to fund the government through Dec. 11, by a vote of 359-57.

Why it matters: The bill will avert a government shutdown when funding expires in eight days. Pelosi and House Majority Leader Steny Hoyer (D-Md.) said earlier that they hoped to hold a vote on the legislation on Tuesday evening.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!